Denis Bedoret biography
Dr. Denis Bedoret serves as President of Masthercell Global of the Company.A. of the Company. Dr. Bedoret has served as the General Manager of MaSTherCell since his appointment on July 6, 2017. Dr. Bedoret joined MaSTherCell in October 2016 as Chief Business and Administration Officer. Prior to joining MaSTherCell, from January 2014 to September 2016, he held the position of Chief Operations Officer at Quality Assistance, a leading European analytical CRO where he was also member of the board of directors. Between September 2011 and January 2014, Dr. Bedoret served as Engagement Manager at McKinsey & Company, focusing on bio-pharmaceutical projects. Through those experiences, he gained a strong expertise in biologicals, FDA and EMA regulations, as well as team management.
What is the salary of Denis Bedoret?
As the President of Masthercell Global of Orgenesis Inc, the total compensation of Denis Bedoret at Orgenesis Inc is $345,725. There are 4 executives at Orgenesis Inc getting paid more, with Vered Caplan having the highest compensation of $1,577,660.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
How old is Denis Bedoret?
Denis Bedoret is 39, he's been the President of Masthercell Global of Orgenesis Inc since 2019. There are 12 older and no younger executives at Orgenesis Inc. The oldest executive at Orgenesis Inc is Prof. Sarah Ferber Ph.D., 67, who is the Founder & Chief Scientific Officer.
What's Denis Bedoret's mailing address?
Denis's mailing address filed with the SEC is C/O ORGENESIS INC., 20271 GOLDENROD LANE, GERMANTOWN, MD, 20876.
Insiders trading at Orgenesis Inc
Over the last 12 years, insiders at Orgenesis Inc have traded over $4,872,134 worth of Orgenesis Inc stock and bought 375,420 units worth $216,187 . The most active insiders traders include Sca Theodorus, Ii Sa Theodorus e Olivier Belenger. On average, Orgenesis Inc executives and independent directors trade stock every 263 days with the average trade being worth of $1,118,704. The most recent stock trade was executed by Victor Miller on 1 April 2024, trading 25,000 units of ORGS stock currently worth $12,500.
What does Orgenesis Inc do?
orgenesis inc (orgs) is a medical device company located in 21 sparrow cir, white plains, new york, united states.
What does Orgenesis Inc's logo look like?
Orgenesis Inc executives and stock owners
Orgenesis Inc executives and other stock owners filed with the SEC include:
-
Vered Caplan,
Chairperson of the Board of Directors, Chief Executive Officer -
Vered Caplan M.Sc.,
Chairperson of the Board, CEO & Pres -
Darren Head,
Chief Executive Officer of Masthercell Global -
Neil T. Reithinger CPA,
CFO, Sec. & Treasurer -
Denis Bedoret,
President of Masthercell Global -
Sarah Ferber,
Chief Scientific Officer -
Neil Reithinger,
Chief Financial Officer, Treasurer, Secretary -
David Sidransky,
Independent Director -
Guy Yachin,
Independent Director -
Yaron Adler,
Independent Director -
Ashish Nanda,
Independent Director -
Mario Philips,
Independent Director -
Vincent Vandamme,
Sr. VP of Quality Strategy -
Lilach Harel,
VP of Global HR -
Osher Partok Rheinisch,
Gen. Counsel & Compliance Officer -
Dr. Shimon Hassin Ph.D.,
Chief Technology Officer -
Joseph Green,
Chief Operating Officer -
Evan Fishman,
Chief Financial Officer -
Prof. Sarah Ferber Ph.D.,
Founder & Chief Scientific Officer -
Elliot Maltz,
Chief Financial Officer -
Olivier Belenger,
-
Hugues Bultot,
Director -
Libre De Bruxelles Universite,
-
Ii Sa Theodorus,
-
Sca Theodorus,
-
Etti Hanochi,
Director -
Itzhak Vider,
Director -
Victor Miller,
CHIEF FINANCIAL OFFICER -
Jacob Safier,
10% owner -
Mark Goodman,
Director -
Kunik Efrat Assa,
Chief Development Officer